Therapeutic agent

Active Tdcs

PreliminaryEvidence level
2Registered trials
1Conditions
0Study references

Evidence Summary

Evidence Level
Preliminary
Mechanism
Enrollment: Actual, Neurological / Autonomic, Sponsor Type: Other, Unknown / General
Safety
Limited specific safety data in these populations. Review full prescribing information and consult specialist. Many agents used off-label or investigational.
Dosing
See linked studies/trials for reported doses and durations; typical protocols vary widely.
Investigational for listed conditions. 2 associated trial(s) and 0 study reference(s) in current data. Review primary sources and consult specialists before use.

Clinical Trials

2 trial(s) registered

NCT IDTitlePhaseStatus
NCT05092516Home-based Brain Stimulation Treatment for Post-acute Sequelae of COVID-19 (PASC)Not applicableActive, not recruiting
NCT05589272TDCS-potentiated Generalization of Cognitive Training in the Rehabilitation of Long COVID SymptomsNot applicableWithdrawn

Key Studies / References

  • See linked studies